THE LONG-RUMOURED iWatch, which Apple might or might not launch this year, reportedly will sport a rounded face like the Android Wear-powered Moto 360.
So said Rosenblatt Securities analyst Brian Blair, who - citing sources within the Taiwan supply chain - said that the iWatch will have a round face, despite expectations that it will be rectangular in design. Blair told Business Insider that the watch will look similar to Motorola's Moto 360, but will have a "slimmer profile".
Interestingly, Blair said that the iWatch will be made available in two different models, likely one for men and one for women. That mirrors earlier rumours, with KGI Securities analyst Ming Chi Kuo having claimed that the wearable will be made available in multiple versions, the most expensive of which could go on sale for "several thousand dollars".
Koh added that these multiple versions will include 1.3in and 1.5in versions, and will feature a battery sized between 200mAh and 250mAh that will "outperform" other smartwatch batteries.
Beyond that, we don't know much more about the rumoured smartwatch yet. However, it likely will arrive running iOS 8, which is expected to debut at WWDC on Monday, and likely will play a key role in Apple's upcoming Healthbook app. This suggests that, much like the Samsung Gear 2, the iWatch will come with features such as a heart rate monitor and a built-in pedometer.
Other rumours have suggested that the Apple iWatch will also feature a curved display, and will come with built-in wireless charging capability.
In contrast to earlier reports that the iWatch is already being built, Blair said that the iWatch will go into production around "July/August". He forecast that Apple will make 18-21 million iWatches for the second half of the year, up from his previous estimate of 15-20 million.
There's no word on a release date yet, and Apple has yet to acknowledge the speculation. µ
For when you just can't take another long lunch break
Control your Android TV from an iOS device? Um, no
Somebody call the irony police
Agreement with the Royal Free NHS Trust doesn't give option to opt-out